These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30659549)

  • 21. Aripiprazole combined with other psychotropic drugs in pregnancy: two case reports.
    Pirec V; Mehta A; Shoush S
    Isr J Psychiatry Relat Sci; 2014; 51(2):135-6. PubMed ID: 25372563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of aripiprazole for delirium in the elderly: a short review.
    Kirino E
    Psychogeriatrics; 2015 Mar; 15(1):75-84. PubMed ID: 25514894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aripiprazole alone or in combination for acute mania.
    Brown R; Taylor MJ; Geddes J
    Cochrane Database Syst Rev; 2013 Dec; (12):CD005000. PubMed ID: 24346956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hypothermia during Treatment with Aripiprazole].
    Kozian R; Schmid G; Demian S
    Psychiatr Prax; 2019 Jan; 46(1):49-51. PubMed ID: 30149396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolonged QRS Widening After Aripiprazole Overdose.
    Mazer-Amirshahi M; Porter R; Dewey K
    Pediatr Emerg Care; 2019 Nov; 35(11):e209-e212. PubMed ID: 29746361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-dose Aripiprazole Induced Enuresis Continuum in a Child.
    Karatoprak S; Uzun N
    Clin Neuropharmacol; 2020; 43(4):123-124. PubMed ID: 32541331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Switching from antipsychotics to aripiprazole and risk of agitation].
    Chaumette B; Masson M; Barde M; Gay O; Gaillard R
    Encephale; 2018 Feb; 44(1):88-90. PubMed ID: 28552242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rationale and design of the PLACID study: a randomised trial comparing the efficacy and safety of inhaled loxapine versus IM aripiprazole in acutely agitated patients with schizophrenia or bipolar disorder.
    San L; Estrada G; Oudovenko N; Vieta E
    BMC Psychiatry; 2017 Apr; 17(1):126. PubMed ID: 28376877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toxicology and overdose of atypical antipsychotics.
    Minns AB; Clark RF
    J Emerg Med; 2012 Nov; 43(5):906-13. PubMed ID: 22555052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determining Whether a Definitive Causal Relationship Exists Between Aripiprazole and Tardive Dyskinesia and/or Dystonia in Patients With Major Depressive Disorder, Part 2: Preclinical and Early Phase Human Proof of Concept Studies.
    Macaluso M; Flynn A; Preskorn S
    J Psychiatr Pract; 2016 Jan; 22(1):42-9. PubMed ID: 26813487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aripiprazole-Induced Hyperlipidemia: An Update.
    Tarraf C; Naja WJ
    Prim Care Companion CNS Disord; 2016 Aug; 18(4):. PubMed ID: 27828697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic effectiveness and tolerability of aripiprazole as initial choice of treatment in first episode psychosis in an early intervention service: A one-year outcome study.
    Malla A; Mustafa S; Rho A; Abadi S; Lepage M; Joober R
    Schizophr Res; 2016 Jul; 174(1-3):120-125. PubMed ID: 27157800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review.
    Newcomer JW
    CNS Drugs; 2005; 19 Suppl 1():1-93. PubMed ID: 15998156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pyrilamine-induced prolonged QT interval in adolescent with drug overdose.
    Paudel G; Syed M; Kalantre S; Sharma J
    Pediatr Emerg Care; 2011 Oct; 27(10):945-7. PubMed ID: 21975494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overdoses and ingestions of second-generation antipsychotics in children and adolescents.
    Antia SX; Sholevar EH; Baron DA
    J Child Adolesc Psychopharmacol; 2005 Dec; 15(6):970-85. PubMed ID: 16379518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of Extrapyramidal Adverse Events With Aripiprazole.
    Etminan M; Procyshyn RM; Samii A; Carleton BC
    J Clin Psychopharmacol; 2016 Oct; 36(5):472-4. PubMed ID: 27580493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tardive Dyskinesia and Covert Dyskinesia with Aripiprazole: A Case Series.
    Patra S
    Curr Drug Saf; 2016; 11(1):102-3. PubMed ID: 26391425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leukocytopenia in patients treated with multiple antipsychotics, including aripiprazole and quetiapine.
    Tomita T; Goto H; Chiba T; Tairabune T; Yoshida T; Tanaka K; Kudo K; Kohda Y
    Psychiatry Clin Neurosci; 2017 Jan; 71(1):71-72. PubMed ID: 27743457
    [No Abstract]   [Full Text] [Related]  

  • 39. Urinary retention associated with aripiprazole: Report of a new case and review of the literature.
    Boyer MG; Kheloufi F; Denis J; Micallef J; Milh M
    Therapie; 2018; 73(3):287-289. PubMed ID: 29146041
    [No Abstract]   [Full Text] [Related]  

  • 40. Drug safety evaluation of aripiprazole in bipolar disorder.
    Cuomo A; Beccarini Crescenzi B; Goracci A; Bolognesi S; Giordano N; Rossi R; Facchi E; Neal SM; Fagiolini A
    Expert Opin Drug Saf; 2019 Jun; 18(6):455-463. PubMed ID: 31072228
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.